In adults with newly diagnosed immune thrombocytopenia (XPAG-ITP trial), first-line eltrombopag plus high-dose dexamethasone vs dexamethasone alone showed qualitatively longer response and less rescue medication; responders had high baseline T-cell clonality.
RCT
Jauch et al. Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia